• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Naomi Kresge

Stay informed with Naomi Kresge’s coverage and analysis.

A U.K. study finds that Pfizer’s vaccine is less effective against Delta 90 days after full vaccination
Health
A U.K. study finds that Pfizer’s vaccine is less effective against Delta 90 days after full vaccination
By Naomi Kresge and BloombergAugust 19, 2021
Children with COVID usually recover within a week, according to a U.K. study
Health
Children with COVID usually recover within a week, according to a U.K. study
By Naomi Kresge and BloombergAugust 4, 2021
BioNTech plans on developing a vaccine that prevents Malaria
Health
BioNTech plans on developing a vaccine that prevents Malaria
By Naomi Kresge and BloombergJuly 26, 2021
Shares in Musk-promoted CureVac plunge after vaccine study shows only 47% efficacy
Health
Shares in Musk-promoted CureVac plunge after vaccine study shows only 47% efficacy
By Naomi Kresge and BloombergJune 17, 2021
Johnson & Johnson to delay Europe vaccine rollout amid U.S. pause over six blood clot cases
Health
Johnson & Johnson to delay Europe vaccine rollout amid U.S. pause over six blood clot cases
By Marthe Fourcade, Naomi Kresge and BloombergApril 13, 2021
After just one dose of the Pfizer-BioNTech vaccine, hospitalizations are down 92%, Israeli study shows
Health
After just one dose of the Pfizer-BioNTech vaccine, hospitalizations are down 92%, Israeli study shows
By Naomi Kresge, Jason Gale and BloombergFebruary 25, 2021
WHO reaffirms safety of Pfizer BioNTech vaccine for elderly patients after Norway scare
Health
WHO reaffirms safety of Pfizer BioNTech vaccine for elderly patients after Norway scare
By Naomi Kresge and BloombergJanuary 22, 2021
Sick patients over 80 could be a COVID vaccine risk, Norwegian health officials warn
Health
Sick patients over 80 could be a COVID vaccine risk, Norwegian health officials warn
By Lars Erik Taraldsen, Naomi Kresge and BloombergJanuary 15, 2021
EU regulators approve Moderna’s COVID vaccine as pressure builds to speed up immunizations
Health
EU regulators approve Moderna’s COVID vaccine as pressure builds to speed up immunizations
By Naomi Kresge and BloombergJanuary 6, 2021
EU seeks an additional 300 million Pfizer-BioNTech vaccine doses
Health
EU seeks an additional 300 million Pfizer-BioNTech vaccine doses
By Naomi Kresge, John Follain and BloombergJanuary 5, 2021
BioNTech CEO says its joint vaccine with Pfizer will likely work on new U.K. virus variant
Health
BioNTech CEO says its joint vaccine with Pfizer will likely work on new U.K. virus variant
By Naomi Kresge and BloombergDecember 22, 2020
U.K. warns people with history of severe allergic reactions not to get the COVID-19 vaccine
Health
U.K. warns people with history of severe allergic reactions not to get the COVID-19 vaccine
By Naomi Kresge, Emily Ashton and BloombergDecember 9, 2020
US-HEALTH-MODERNA
Moderna has never distributed a product before. A Swiss company is here to help
By Naomi Kresge and BloombergNovember 19, 2020
Santander buys assets from Wirecard, as failed payments company is wound down
Finance
Santander buys assets from Wirecard, as failed payments company is wound down
By Naomi Kresge and BloombergNovember 17, 2020
Pfizer and BioNTech take the lead after study shows their vaccine prevents 90% of infections
Health
Pfizer and BioNTech take the lead after study shows their vaccine prevents 90% of infections
By Robert Langreth, Naomi Kresge, Riley Griffin and BloombergNovember 9, 2020
1
  • 1
  • 2
  • 3
  • 4
4
Most Popular
Law
Egg companies made $1.22 billion in profit off a $6 carton — now they’re buying their way out of a price-fixing case with 53 million donated eggsplaceholder alt text
By Wyatte Grantham-Philips and The Associated PressJuly 2, 2026
Success
Even as Elon Musk calls philanthropy ‘very hard,’ everyday Americans gave a record $617 billion—despite feeling the squeeze over the cost of livingplaceholder alt text
By Preston ForeJuly 4, 2026
AI
Meet the Zillennials: The luckiest micro-generation in the workforce, born between 1993 and 1998placeholder alt text
By Nick LichtenbergJuly 3, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.